PetMed Express (FRA:PQM) EBIT per Share : €-0.09 (TTM As of Sep. 2024)

View and export this data going back to 1997. Start your Free Trial

What is PetMed Express EBIT per Share?

PetMed Express's EBIT per Share for the three months ended in Sep. 2024 was €0.02. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.09.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for PetMed Express's EBIT per Share or its related term are showing as below:

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of PetMed Express was 140.00% per year. The lowest was -42.20% per year. And the median was 8.20% per year.

FRA:PQM's 3-Year EBIT Growth Rate is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 8.55
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

PetMed Express's EBIT for the three months ended in Sep. 2024 was €0.5 Mil.

PetMed Express EBIT per Share Historical Data

The historical data trend for PetMed Express's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PetMed Express EBIT per Share Chart

PetMed Express Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT per Share

Get a 7-Day Free Trial

1.40

1.28

1.08

0.28

-0.37

PetMed Express Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial															0.04	-0.14	-0.17	0.20	0.02

PetMed Express EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

PetMed Express's EBIT per Share for the fiscal year that ended in Mar. 2024 is calculated as

	EBIT per Share		(A: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-7.509	/	20.396
=	-0.37

PetMed Express's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	0.499	/	20.939
=	0.02

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.09

PetMed Express (FRA:PQM) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

PetMed Express EBIT per Share Related Terms

Thank you for viewing the detailed overview of PetMed Express's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

PetMed Express Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PetMed Express Inc (FRA:PQM) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

PETS:USA PQM:Germany

Address

420 South Congress Avenue, Suite 100, Delray Beach, FL, USA, 33445

Website

https://www.petmeds.com

PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.

PetMed Express Headlines

No Headlines